What is Natera Inc (NTRA)?
Natera Inc is a biotechnology company specializing in genetic testing and diagnostics. The company develops and commercializes non-invasive tests that analyze cell-free DNA to provide insights into reproductive health, oncology, and organ transplantation. Its product portfolio includes prenatal screening, cancer detection, and transplant rejection monitoring tests. Natera's technology integrates advanced molecular biology with proprietary bioinformatics algorithms to enhance the accuracy and reliability of its assays. The company collaborates with healthcare providers, researchers, and pharmaceutical companies to support personalized medicine and improve patient outcomes. Natera operates in a highly regulated environment, adhering to standards set by health authorities to ensure the quality and safety of its diagnostic services. Its contributions to genetic testing have influenced clinical decision-making processes and expanded the applications of liquid biopsy techniques. The company is headquartered in the United States and maintains a network of laboratories and partnerships to facilitate the delivery of its testing services globally.
Natera Inc Stock Price Today: Live Overview
The price today is shaped by ongoing trades, with Natera Inc priced at $195.47. Its intraday range falls between $192.95 and $200.84, accompanied by a daily percentage move of 0%.
FAQ: Natera Inc (NTRA)
What is the current price of NTRA stock?
The last traded price is $195.47.
Does NTRA pay dividends?
Natera Inc does not pay dividends.
Does NTRA have a formal corporate presence or regional headquarters in the UAE?
Natera Inc operates in the UAE through local partners without an official office or subsidiary.
What is NTRA best known for?
Natera Inc is most famous for its genetic testing and diagnostics services.
What assets are typically shown together with NTRA?
Commonly shown alongside NTRA: Merit Medical Systems Inc, Diasorin, STAAR Surgical Co
Latest shares articles



